News Tonix launches its new fibromyalgia drug in US Tonix has launched its fibromyalgia therapy Tonmya in the US, the first new drug for the painful condition in more than 16 years.
News Wearable alert system for epileptics set for European launch An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.
News Vaderis drug lends hope to patients with bleeding disease HH... A trial of Vaderis' AKT inhibitor engasertib finds it could be the first effective treatment for rare disease hereditary haemorrhagic telangiectasia.
News Platform tests commercial algorithms for NHS use for bias A platform that can test whether AI algorithms developed for NHS applications are fit for purpose and free of bias has shown its value in a new study.
News FDA starts priority review of BeOne's Venclexta rival BeOne nears a possible FDA okay for sonrotoclax in mantle cell lymphoma, hoping to be the second BCL-2 inhibitor in the US after AbbVie's Venclexta.
News Lundbeck bows out of bidding war for Avadel Lundbeck won't raise its offer to buy Avadel any further, clearing the way for the sleep disorder specialist to complete a merger with Alkermes.
Digital On the future of AI in life sciences, with women at the helm Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
